Loading clinical trials...
Loading clinical trials...
To evaluate the safety and feasibility of the Calibreye System in patients with open angle glaucoma.
This is a prospective, nonrandomized, open-label feasibility clinical trial, to evaluate the surgical procedure, safety and effectiveness of the Calibreye System in reducing intraocular pressure in subjects with open angle glaucoma.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Dr. Agarwal's Eye Hospital Ltd.
Chennai, India
Centro Oftalmologico de Chihuahua
Chihuahua City, Mexico
Oftalmología Láser de Puebla S.C.
Puebla City, Mexico
Panama Eye Center
Panama City, Panama
Start Date
May 31, 2023
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2028
Last Updated
December 15, 2025
60
ESTIMATED participants
Calibreye System
DEVICE
Lead Sponsor
Myra Vision Inc.
NCT06201455
NCT05624398
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions